Human Genome, Democrasoft, Apple: Intellectual Property
This article is for subscribers only.
Human Genome Sciences Inc., a pharmaceutical developer, sued Roche Holding AG’s Genentech unit alleging the company created a three-decade “monopoly” for technology used to make medicine to treat lupus.
HGS, based in Rockville, Maryland, said South San Francisco, California-based Genentech circumvented the federal patent process by withholding information and initiating “sham” litigation to ensure protection for antibody therapeutics, according to a Feb. 18 complaint filed in Wilmington, Delaware.